在帕金森病中探索GBA1基因:亚洲小区的流行率和变异谱
Merve Koç Yekedüz1,2, Rezzak Yilmaz3,4, Talha Abali5
1Department of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey. drmervekoc13@hotmail.com.
概括
这项研究在13.2%的土耳其帕金森病患者中发现了GBA1基因变异,比对照群的患病率明显高. 这些变异与早期发病和更严重的运动症状有关.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 帕金森病研究 帕金森病研究
背景情况:
- GBA1基因是已知的帕金森病 (PD) 风险因素之一.
- 有限的数据存在于全球不同人口中的GBA1变异.
- 这项研究重点关注土耳其PD人口.
研究的目的:
- 研究土耳其PD患者中GBA1变异的流行率和类型.
- 探索GBA1变异与PD的临床关联.
- 为了扩大对GBA1在PD中的作用的理解,在一个研究不足的地区.
主要方法:
- 用下一代测序对513名PD患者和203名健康对照群体的GBA1变异进行遗传分析.
- 对于检测到GBA1变异的参与者,整体外基因组测序.
- 收集临床数据并测量酶/基质水平.
主要成果:
- 在PD患者中,GBA1变异存在于13.2%的PD患者中,对照组中为6.4%,患病率高出2.2倍.
- 常见的变异包括p.T369M,p.L444P和p.N370S;确定了15种新的PD相关变异.
- 致病变体与早期发病,较高的勒沃多巴相当剂量和运动并发症相关.
结论:
- 这是土耳其PD患者GBA1变异的最大研究,突出显著的临床影响.
- 这些发现扩大了这个特定地理区域GBA1变异景观的知识.
- 这项研究强调了GBA1基因查在PD管理中的重要性.
更多相关视频
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.4K
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
535
相关概念视频
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Single Nucleotide Polymorphisms-SNPs
16.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.0K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
